News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,521 Results
Type
Article (87800)
Company Profile (824)
Press Release (778880)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233184)
Career Advice (4144)
Deals (39844)
Drug Delivery (144)
Drug Development (91373)
Employer Resources (203)
FDA (18365)
Job Trends (17415)
News (397750)
Policy (39953)
Tag
Academia (3006)
Academic (2)
Accelerated approval (30)
Adcomms (35)
Allergies (136)
Alliances (56981)
ALS (173)
Alzheimer's disease (1764)
Antibody-drug conjugate (ADC) (314)
Approvals (18508)
Artificial intelligence (583)
Autoimmune disease (140)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (194)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (632)
Cancer (4761)
Cardiovascular disease (415)
Career advice (3566)
Career pathing (40)
CAR-T (294)
CDC (59)
Celiac Disease (1)
Cell therapy (794)
Cervical cancer (37)
Clinical research (76655)
Collaboration (1630)
Company closure (5)
Compensation (1087)
Complete response letters (65)
COVID-19 (2981)
CRISPR (94)
C-suite (753)
Cystic fibrosis (148)
Data (5931)
Decentralized trials (2)
Denatured (69)
Depression (133)
Diabetes (502)
Diagnostics (7179)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (278)
Drug pricing (208)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99906)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134593)
Executive appointments (1011)
FDA (21297)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1453)
Gene editing (205)
Generative AI (60)
Gene therapy (635)
GLP-1 (1093)
Government (5429)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (278)
Immuno-oncology (43)
Indications (78)
Infectious disease (3256)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (223)
Interviews (816)
IPO (17946)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10155)
Liver cancer (95)
Longevity (14)
Lung cancer (654)
Lymphoma (366)
Machine learning (40)
Management (66)
Manufacturing (763)
MASH (168)
Medical device (14976)
Medtech (15017)
Mergers & acquisitions (22893)
Metabolic disorders (1312)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (327)
Neuropsychiatric disorders (87)
Neuroscience (2982)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (629)
Opinion (327)
Ovarian cancer (154)
Pain (194)
Pancreatic cancer (206)
Parkinson's disease (278)
Partnered (36)
Patents (475)
Patient recruitment (426)
Peanut (59)
People (66670)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23670)
Phase II (33260)
Phase III (25087)
Pipeline (4067)
Policy (323)
Postmarket research (3554)
Preclinical (10671)
Press Release (72)
Prostate cancer (233)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (823)
Real estate (7437)
Recruiting (80)
Regulatory (28657)
Reports (65)
Research institute (2718)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (150)
Series A (244)
Series B (178)
Service/supplier (30)
Sickle cell disease (101)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (117)
Vaccines (1112)
Venture capital (82)
Weight loss (440)
Women's health (79)
Worklife (21)
Date
Today (100)
Last 7 days (520)
Last 30 days (2478)
Last 365 days (33193)
2025 (33060)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (328)
Arkansas (14)
Asia (51375)
Australia (9024)
California (10915)
Canada (3190)
China (1078)
Colorado (459)
Connecticut (482)
Delaware (330)
Europe (118060)
Florida (1596)
Georgia (354)
Hawaii (3)
Idaho (68)
Illinois (905)
India (62)
Indiana (527)
Iowa (22)
Japan (398)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1402)
Massachusetts (8080)
Michigan (344)
Minnesota (634)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (81)
New Jersey (2975)
New Mexico (32)
New York (2913)
North Carolina (1542)
North Dakota (10)
Northern California (5156)
Ohio (332)
Oklahoma (22)
Oregon (52)
Pennsylvania (2212)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4193)
Tennessee (169)
Texas (1723)
United States (39687)
Utah (326)
Vermont (1)
Virginia (275)
Washington D.C. (85)
Washington State (922)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,521 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
·
5 min read
Press Releases
Sale of Intellectual Property – Mythic Therapeutics Inc.
December 23, 2025
·
1 min read
Press Releases
A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors
December 23, 2025
·
6 min read
Press Releases
Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01
December 23, 2025
·
9 min read
Press Releases
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026
December 23, 2025
·
5 min read
Press Releases
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026
December 23, 2025
·
3 min read
GLP-1
Novo’s Wegovy Pill Wins Obesity Approval, Securing Lead in Oral GLP-1 Race
Analysts called the approval a much-needed win for Novo Nordisk, but warned that the company could struggle to grow sales once rival drugs come to market.
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Neuroscience
Neurocrine’s Valbenazine Fails Phase III Neurodevelopmental Disorder Trial
Analysts said the outcome is disappointing because there are no approved treatments for dyskinetic cerebral palsy, but the setback had little impact on Neurocrine’s valuation.
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
The banker allegedly shared details of a series of multibillion-dollar buyouts by companies including AbbVie, GSK and Pfizer.
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Clinical research
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A
The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.
December 23, 2025
·
1 min read
·
Annalee Armstrong
1 of 86,753
Next
